CorMedix Inc (NASDAQ: CRMD) Q4 2020 earnings call dated Mar. 30, 2021. Corporate Participants: Dan Ferry -- Investor Relations Khoso Baluch -- Chief Executive Officer Phoebe
CorMedix Inc
-(CRMD)
XASE:CRMD
Earnings calendar for the week of March 29
Encouraging data from the labor market and optimism brought on by the stimulus package bolstered stock markets this week. Benchmark indexes Dow
CorMedix (NYSE: CRMD): Q4 2019 Earnings Snapshot
-- CorMedix Inc. (NYSE: CRMD) reported a fourth-quarter 2019 loss of $0.21 per share versus a loss of $0.24 per share expected.
CorMedix, Inc. (NYSE: CRMD): Q3 2019 Earnings Snapshot
-- CorMedix, Inc. (NYSE: CRMD) reported a net loss attributable to common shareholders of $32.4 million or $1.35 per share for the
CorMedix reports upbeat Q1 results; provides business update
Biopharmaceutical company CorMedix (CRMD) reported its first quarter 2019 results after the bell today. CorMedix recorded a net loss of $5.2 million
Q4 Earnings Preview: All eyes on Neutrolin trial updates from CorMedix
Biopharma firm CorMedix (NYSE American: CRMD) has seen its shares skyrocket more than 500% in the last 12 months as investors are